Nektar Therapeutics ( NKTR) - Stock Earnings
NKTR Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
NKTR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -36.1 million USD | 21.8 million USD |
| 2026Q1 | -44.9 million USD | 10.9 million USD |
| 2026Q2 | -40.6 million USD | 10.1 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
NKTR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -276.1 million USD | 90.1 million USD |
| 2024 | -119.0 million USD | 98.4 million USD |
| 2025 | -164.1 million USD | 55.2 million USD |
| 2026 Est. | — | — |
NKTR
Price: $35.78
Earnings Per Share: -6.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.8 million
Ebitda: 74.9 millionMarket Capitalization: 1.1 billion